Cutaneous melanoma - Past, present, and future

Journal of the American Academy of Dermatology

Volumn 51, Issue 1 SUPPL., 2004, Pages 65-69

  Schaffer, Julie V ^a   Rigel, Darrell S ^b   Kopf, Alfred W ^b   Bolognia, Jean L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; DACARBAZINE; INTERLEUKIN 2;

AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER STAGING; CORRELATION ANALYSIS; DISEASE COURSE; DYSPLASTIC NEVUS; EPIDEMIC; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MALIGNANT LENTIGO; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; MITOSIS RATE; MORBIDITY; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE BIOPSY; SEX RATIO; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNITED STATES;

EID: 3042773175     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.01.030     Document Type: Article

References (10)

1. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER Cancer Statistics Review, 1973-2001. 2004;National Cancer Institute, Bethesda, MD. Available from: http://seer.cancer.gov/csr/1975_2001. Accessed May, 2004
2. Consensus Development Panel on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA. 268:1992;1314-1319
3. Marghoob A.A., Swindle L., Moricz C.Z., Sanchez Negron F.A., Slue B., Halpern A.C., et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol. 49:2003;777-797
4. Clark W.H. Jr., Reimer R.R., Green M., Ainsworth A.M., Mastrangelo M.J. Origin of familial malignant melanomas from heritable melanocytic lesions. "The B-K mole syndrome" Arch Dermatol. 114:1978;732-738
5. Lynch H.T., Frichot B.C. III, Lynch J.F. Familial atypical multiple mole melanoma syndrome. J Med Genet. 15:1978;352-356
6. Chin L. The genetics of malignant melanoma: Lessons from mouse and man. Nat Rev. 3:2003;559-570
7. Breslow A. Thickness, cross-sectional areas, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 172:1970;902-908
8. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 19:2001;3635-3648
9. Dubois R.W., Swetter S.M., Atkins M., McMasters K., Halbert R., Miller S.J., et al. Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. Arch Dermatol. 137:2001;1217-1224
10. Sober A.J., Fitzpatrick T.B., Mihm M.C. Primary melanoma of the skin: Recognition and management. J Am Acad Dermatol. 2:1980;179-197